Anemia

News

Combo worsens platelet recovery in MDS

Results from the phase 3 SUPPORT trial suggest there is no role for the combination of eltrombopag and azacitidine in patients with intermediate-...

MD IQ

Conference Coverage

Sickle cell disease gene therapy seen advancing

BETHESDA, MD. – NIH conference highlights experimental gene therapies for SCD and thalassemia, with further updates on this work slated for ASH’s...

News

Links between SCT and adverse outcomes

Although sickle cell trait (SCT) has been linked to adverse clinical outcomes in multiple studies, only a handful of associations have strong...

Pages